|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000175634 |
Summary for RPS6KB2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000175634 | Gene symbol | RPS6KB2 |
| Gene name | ribosomal protein S6 kinase B2 | |
| HGNC | 10437 | |
| Entrez ID | 6199 | |
| Gene type | protein_coding | |
| Synonyms | RPS6KB2|p70S6Kb|P70-BETA|STK14B|KLS|S6KB|S6Kbeta|S6Kβ | |
| UniProtAcc | Q9UBS0 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for RPS6KB2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| RPS6KB2 | 3.29e+03 | 1.03e+00 | 1.68e-01 | 6.14e+00 | 8.03e-10 | 5.19e-09 | LUSC |
Top |
Sex-biased somatic mutation for RPS6KB2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for RPS6KB2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for RPS6KB2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| KICH | exon_skip_61919 | 9.60e-01 | 8.36e-01 | 4.61e+00 | 4.08e-06 | 5.76e-04 | 1.24e-01 |
Top |
RNA A-to-I editing events in TCGA for RPS6KB2 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for RPS6KB2 |
TFs related to RPS6KB2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | MYC | RPS6KB2 | 3.03e+00 | 6.44e-03 | 4.37e+00 | 9.81e-01 | Female-biased |
| BRCA | PLAGL2 | RPS6KB2 | 3.11e+00 | 2.99e-03 | 4.71e+00 | 9.90e-01 | Female-biased |
| BRCA | ZNF692 | RPS6KB2 | 2.97e+00 | 4.75e-03 | 4.41e+00 | 9.84e-01 | Female-biased |
RPS6KB2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for RPS6KB2 |
RBPs related to ES in RPS6KB2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | SAMD4A | exon_skip_61919 | 8.08e+00 | 1.19e-02 | 8.41e+00 | 9.81e-01 | Female-biased |
| ACC | SAMD4A | exon_skip_61919 | 8.73e+00 | 9.92e-01 | 8.06e+00 | 2.01e-03 | Male-biased |
| UVM | SRSF9 | exon_skip_61965 | 8.11e+00 | 9.83e-01 | 7.81e+00 | 8.61e-03 | Male-biased |
| CHOL | SAMD4A | exon_skip_61919 | 8.34e+00 | 4.56e-03 | 8.85e+00 | 9.90e-01 | Female-biased |
| KIRP | SAMD4A | exon_skip_61919 | 8.73e+00 | 9.89e-01 | 8.34e+00 | 5.06e-03 | Male-biased |
| BRCA | SAMD4A | exon_skip_61919 | 8.68e+00 | 9.92e-01 | 7.77e+00 | 1.68e-03 | Male-biased |
| ESCA | SAMD4A | exon_skip_61919 | 8.69e+00 | 9.88e-01 | 8.20e+00 | 7.04e-03 | Male-biased |
| KIRC | SAMD4A | exon_skip_61956 | 6.47e+00 | 9.81e-01 | 6.00e+00 | 1.32e-03 | Male-biased |
| KICH | SAMD4A | exon_skip_61919 | 8.15e+00 | 4.48e-03 | 8.54e+00 | 9.89e-01 | Female-biased |
| BLCA | SRSF9 | exon_skip_61965 | 8.49e+00 | 9.80e-01 | 8.15e+00 | 1.30e-02 | Male-biased |
RPS6KB2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs74700252 | chr11:72265073:C:T | - | 0.204352214009548 | 0.00519425894437488 | BLCA | Female-baised eQTL |
| rs59980097 | chr11:72265919:A:G | - | 0.204352214009548 | 0.00519425894437488 | BLCA | Female-baised eQTL |
| rs59509230 | chr11:72266029:C:T | - | 0.204352214009548 | 0.00519425894437488 | BLCA | Female-baised eQTL |
| rs74978386 | chr11:72267742:C:A | - | 0.186272548913585 | 0.0125590532565188 | BLCA | Female-baised eQTL |
| rs59427981 | chr11:72268335:A:G | - | 0.186272548913585 | 0.0125590532565188 | BLCA | Female-baised eQTL |
| rs141875220 | chr11:72268566:C:A | - | 0.186272548913585 | 0.0125590532565188 | BLCA | Female-baised eQTL |
| rs146066511 | chr11:72268575:A:C | - | 0.186272548913585 | 0.0125590532565188 | BLCA | Female-baised eQTL |
| rs56229279 | chr11:72302744:A:G | - | 0.167484461880107 | 0.0208629070630395 | BLCA | Female-baised eQTL |
| rs487288 | chr11:72285783:G:T | - | 0.165879789774474 | 0.0241725557012583 | BLCA | Female-baised eQTL |
| rs2508866 | chr11:72286090:A:C | - | 0.165879789774474 | 0.0241725557012583 | BLCA | Female-baised eQTL |
| rs56333926 | chr11:72273563:A:C | - | 0.164702018797927 | 0.0412624957780704 | BLCA | Female-baised eQTL |
| rs55723921 | chr11:72275419:C:T | - | 0.164106699667042 | 0.0429119190085525 | BLCA | Female-baised eQTL |
| rs7108974 | chr11:72280643:C:T | - | 0.164106699667042 | 0.0429119190085525 | BLCA | Female-baised eQTL |
| rs1783632 | chr11:72287281:A:C | - | 0.162561134353216 | 0.0484231817432508 | BLCA | Female-baised eQTL |
| rs3019563 | chr11:61070349:A:G | - | -0.0950589254162906 | 0.00832290734883584 | LUAD | Female-baised eQTL |
| rs3015954 | chr11:61091106:C:T | - | 0.0901362307722614 | 0.0158445483217186 | LUAD | Female-baised eQTL |
| rs3019551 | chr11:61086727:A:G | - | 0.0862085410703596 | 0.0191521859153386 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs61897411 | chr11:75482169:C:T | - | 0.0903041292972292 | 0.034486686536602 | LIHC | Male-baised eQTL |
| rs78988502 | chr11:75482262:C:G | - | 0.0903041292972292 | 0.034486686536602 | LIHC | Male-baised eQTL |
| rs77447468 | chr11:75484651:G:A | - | 0.0903041292972292 | 0.034486686536602 | LIHC | Male-baised eQTL |
| rs56386896 | chr11:75496262:A:G | - | 0.0906500234220556 | 0.0352527624737927 | LIHC | Male-baised eQTL |
| rs61897414 | chr11:75489882:G:T | - | 0.090023889145349 | 0.0355462792074581 | LIHC | Male-baised eQTL |
| rs2187568 | chr11:75490628:C:T | - | 0.090023889145349 | 0.0355462792074581 | LIHC | Male-baised eQTL |
| rs61897415 | chr11:75492011:T:A | - | 0.090023889145349 | 0.0355462792074581 | LIHC | Male-baised eQTL |
| rs61897416 | chr11:75494867:G:A | - | 0.090023889145349 | 0.0355462792074581 | LIHC | Male-baised eQTL |
| rs61897406 | chr11:75477215:G:A | - | 0.0931522695197477 | 0.0378222978574643 | LIHC | Male-baised eQTL |
| rs55955041 | chr11:75480368:T:C | - | 0.0888826862870394 | 0.0408926769223774 | LIHC | Male-baised eQTL |
| rs61897410 | chr11:75481494:T:C | - | 0.0892548530845658 | 0.0417764288199215 | LIHC | Male-baised eQTL |
| rs73494872 | chr11:75463125:C:G | - | 0.0925697267377011 | 0.0447175245538195 | LIHC | Male-baised eQTL |
| rs3814715 | chr11:75451709:A:G | - | 0.0767813594086767 | 0.0487233286089556 | LIHC | Male-baised eQTL |
| rs79513707 | chr11:63967788:G:C | - | 0.0987893848071644 | 0.00845145942288747 | KIRC | Male-baised eQTL |
| rs614047 | chr11:64350950:G:C | - | 0.0725698794250949 | 0.0154452209904328 | COAD | Male-baised eQTL |
| rs658623 | chr11:74856446:A:C | - | -0.0856992224427781 | 0.0199304660086526 | COAD | Male-baised eQTL |
| rs61375303 | chr11:70520115:T:A | - | -0.0581475981710497 | 0.0327991536377625 | COAD | Male-baised eQTL |
| rs676309 | chr11:60234100:T:C | - | 0.044848530955881 | 0.0336426513293396 | COAD | Male-baised eQTL |
| rs678384 | chr11:60234719:T:G | - | 0.044848530955881 | 0.0336426513293396 | COAD | Male-baised eQTL |
| rs12221613 | chr11:60234789:A:C | - | 0.044848530955881 | 0.0336426513293396 | COAD | Male-baised eQTL |
| rs56996352 | chr11:70520114:C:G | - | -0.0577956114490928 | 0.03368405271074 | COAD | Male-baised eQTL |
| rs1285231 | chr11:60211935:T:C | - | 0.0436497722162611 | 0.0380194550477003 | COAD | Male-baised eQTL |
| rs1151119 | chr11:60212459:G:A | - | 0.0436497722162611 | 0.0380194550477003 | COAD | Male-baised eQTL |
| rs603568 | chr11:60214146:T:C | - | 0.0436497722162611 | 0.0380194550477003 | COAD | Male-baised eQTL |
| rs670854 | chr11:60214296:T:C | - | 0.0436497722162611 | 0.0380194550477003 | COAD | Male-baised eQTL |
| rs621965 | chr11:60237355:G:A | - | 0.0443156815585877 | 0.0382709139524341 | COAD | Male-baised eQTL |
| rs633463 | chr11:60237700:T:G | - | 0.0443156815585877 | 0.0382709139524341 | COAD | Male-baised eQTL |
| rs650943 | chr11:60239292:A:C | - | 0.0443156815585877 | 0.0382709139524341 | COAD | Male-baised eQTL |
| rs604085 | chr11:60209928:G:A | - | 0.0433021293791338 | 0.0424559522937713 | COAD | Male-baised eQTL |
| rs626011 | chr11:60212545:G:A | - | 0.0433021293791338 | 0.0424559522937713 | COAD | Male-baised eQTL |
| rs612738 | chr11:60223118:G:T | - | 0.04339937928162 | 0.0435833899627455 | COAD | Male-baised eQTL |
| rs657928 | chr11:60221433:G:A | - | 0.0427632716517231 | 0.0444689942316563 | COAD | Male-baised eQTL |
| rs11605129 | chr11:69283448:C:T | - | -0.0800447628917185 | 0.0455271628465728 | COAD | Male-baised eQTL |
| rs10896767 | chr11:58391703:A:G | - | -0.0426954462446066 | 0.0461479731306208 | COAD | Male-baised eQTL |
| rs620612 | chr11:60224374:C:T | - | 0.0429173790544239 | 0.0488961852689293 | COAD | Male-baised eQTL |
| rs673996 | chr11:60226679:C:A | - | 0.0429173790544239 | 0.0488961852689293 | COAD | Male-baised eQTL |
| rs688460 | chr11:60219237:C:T | - | 0.0423958815876274 | 0.0496306146814368 | COAD | Male-baised eQTL |
| rs584469 | chr11:60221389:T:C | - | 0.0423958815876274 | 0.0496306146814368 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_61919 | chr11:67428981:67429022 | Frame-shift | rs494865 | chr11:66573980:G:A | Distant upstream | 0.0800959777455583 | 0.0327079330933899 | PCPG | Male-baised sQTL |
| exon_skip_61919 | chr11:67428981:67429022 | Frame-shift | rs1815739 | chr11:66560624:T:C | Distant upstream | 0.0748735197867008 | 0.0487279990476196 | PCPG | Male-baised sQTL |
| exon_skip_61919 | chr11:67428981:67429022 | Frame-shift | rs11606508 | chr11:68289302:C:T | Distant downstream | -0.058473656883722 | 0.0265711410945405 | PAAD | Male-baised sQTL |
| exon_skip_61919 | chr11:67428981:67429022 | Frame-shift | rs3179961 | chr11:66476983:A:G | Distant upstream | -0.0494851347917849 | 0.0446837912819388 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs2290463 | chr11:66561381:G:C | Distant upstream | -0.0840781729237896 | 0.045361608989903 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs146249445 | chr11:66537756:G:A | Distant upstream | -0.0840585040436167 | 0.0454196599320945 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs77618368 | chr11:66483409:T:C | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs74491182 | chr11:66527198:C:T | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs76487247 | chr11:66565281:C:G | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs78871927 | chr11:66566172:G:A | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs77760653 | chr11:66566520:A:G | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs17147749 | chr11:66568713:C:G | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs142988445 | chr11:66571778:G:C | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
| exon_skip_61958 | chr11:67433125:67433216 | Frame-shift | rs117688728 | chr11:66572164:A:G | Distant upstream | -0.0839974064016653 | 0.045471585246976 | PAAD | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_61958 | chr11:67433125:67433216 | cg06837765 | chr11:66559181 | Distant upstream | 0.17036289889682 | 1.81471500871614e-13 | 0.45265342444103507 | 4.113934709877996e-06 | Frame-shift | PAAD |
| exon_skip_61958 | chr11:67433125:67433216 | cg10959896 | chr11:66852493 | Distant upstream | 0.17036289889682 | 1.81471500871614e-13 | 0.7138740807184112 | 4.661691412606001e-16 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg09175485 | chr11:67253084 | Distant upstream | 0.151579151106945 | 1.30296893912513e-09 | 0.40193717882905255 | 5.931973484430077e-05 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg13388983 | chr11:67056669 | Distant upstream | -0.104314101854738 | 2.34489352961806e-08 | -0.7180421979843112 | 3.788799924629755e-16 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg05116382 | chr11:66559529 | Distant upstream | 0.0957235735428093 | 1.04833105070568e-06 | 0.4222404713351049 | 2.2450948035264648e-05 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg03166566 | chr11:67056667 | Distant upstream | -0.130511182028893 | 1.88547512867161e-06 | -0.6397502592613142 | 3.890129942937002e-12 | Frame-shift | PAAD |
| exon_skip_61958 | chr11:67433125:67433216 | cg19836431 | chr11:66852547 | Distant upstream | 0.181509756451779 | 3.39199184105837e-06 | 0.726333736614577 | 8.099927926378122e-17 | Frame-shift | PAAD |
| exon_skip_61958 | chr11:67433125:67433216 | cg17161520 | chr11:67407372 | Distant upstream | 0.181509756451779 | 3.39199184105837e-06 | 0.3313733042859341 | 0.001037076542188432 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg06837765 | chr11:66559181 | Distant upstream | 0.122484340561879 | 1.95392156803485e-05 | 0.47741297778637404 | 1.1425904814263072e-06 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg10959896 | chr11:66852493 | Distant upstream | 0.122484340561879 | 1.95392156803485e-05 | 0.6535115648441285 | 9.333236465772524e-13 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg19784198 | chr11:67271446 | Distant upstream | 0.122190738170414 | 2.1135093479245e-05 | 0.3852574840048181 | 0.00012589877594746803 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg19836431 | chr11:66852547 | Distant upstream | 0.162130049192191 | 9.81295263540332e-05 | 0.611159672314628 | 6.069157639265224e-11 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg09130535 | chr11:67271648 | Distant upstream | 0.162130049192191 | 9.81295263540332e-05 | 0.4694002560586795 | 1.8196525270882741e-06 | Frame-shift | PAAD |
| exon_skip_61919 | chr11:67428981:67429022 | cg17161520 | chr11:67407372 | Distant upstream | 0.162130049192191 | 9.81295263540332e-05 | 0.3223745127636465 | 0.0015308689572158074 | Frame-shift | PAAD |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_61958 | chr11:67433125:67433216 | cg27052183 | chr11:66644515 | Distant upstream | 0.177503891293107 | 3.76779849256791e-06 | 0.5764099663263293 | 2.7151297424627537e-08 | Frame-shift | PAAD |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of RPS6KB2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000175634 | RPS6KB2 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| ENSG00000175634 | RPS6KB2 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| ENSG00000175634 | RPS6KB2 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| ENSG00000175634 | RPS6KB2 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| ENSG00000175634 | RPS6KB2 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |